1. Introduction {#sec1-ijerph-16-04441}
===============

Diabetes is a non-communicable disease \[[@B1-ijerph-16-04441]\]. However, its prevalence is increasing worldwide \[[@B2-ijerph-16-04441]\]. According to International Diabetes Federation (IDF) data, the number of individuals with diabetes worldwide in 2017 was approximately 424.9 million, with a prevalence rate of 8.8%. Moreover, in 2045, its prevalence is predicted to increase up to 9.9% among 6.37 billion adults worldwide \[[@B3-ijerph-16-04441]\]. The increase in its prevalence is a cause of concern because diabetes is one of the major causes of death. According to the World Health Organization (WHO) data, diabetes is the sixth leading cause of death in 2015, with 1.59 million recorded cases \[[@B4-ijerph-16-04441]\]. The leading cause of death among diabetes patients is diabetes complications.

Blood glucose levels that are poorly managed increase the risk of these complications \[[@B5-ijerph-16-04441]\]. In other words, uncontrolled diabetes can cause complications, which can threaten the lives of patients. Therefore, the blood glucose levels (pharmacological or non-pharmacological treatment) of patients with diabetes must be controlled. If the blood glucose levels of patients with diabetes is properly controlled, diabetes-related complications and death can be prevented \[[@B3-ijerph-16-04441]\].

In contrast, depression increases the risk of complications and death among individuals with diabetes. Depression is a well-known comorbidity in patients with chronic diseases, and diabetes is not an exception \[[@B6-ijerph-16-04441]\]. Distress from the condition, depressive mood or symptoms, and clinical depression can be observed in patients with diabetes \[[@B7-ijerph-16-04441]\]. Depressive symptoms in patients with diabetes reduces adherence to treatments \[[@B8-ijerph-16-04441]\] and disrupts the management of high blood glucose. Moreover, they can cause complications and increase the risk of mortality from diabetes \[[@B3-ijerph-16-04441],[@B9-ijerph-16-04441]\]. Diabetes patients with depression have approximately 1.5 times increased risk of mortality compared to diabetes patients without depression \[[@B10-ijerph-16-04441]\]. Thus, depression is fatal in these patients.

In several previous studies, diabetes and depressive symptoms had a bidirectional association \[[@B11-ijerph-16-04441]\]. Both are risk factors that cause each other to occur, and they also exacerbate each other's disease state. Therefore, individuals with diabetes have twice the increased risk for depression than those without \[[@B12-ijerph-16-04441],[@B13-ijerph-16-04441]\]. In particular, among patients with diabetes, emotional distress (including depressive symptoms) is more commonly observed in women than in men \[[@B14-ijerph-16-04441],[@B15-ijerph-16-04441]\]. Approximately 80% of patients with diabetes are more likely to experience a recurrence of depressive symptoms \[[@B16-ijerph-16-04441]\]. Furthermore, treatments for high blood glucose had a negative impact on depression \[[@B17-ijerph-16-04441],[@B18-ijerph-16-04441],[@B19-ijerph-16-04441],[@B20-ijerph-16-04441]\].

According to previous studies, the degree of depressive symptoms among patients with diabetes differed according to the type of treatment for diabetes. Studies that used the problem areas in diabetes (PAID) questionnaire focused on depression, and the emotional problems of the patients with diabetes showed different emotional distresses, which depends on the type of treatment for type 2 diabetes \[[@B15-ijerph-16-04441]\]. In another study that used the PAID questionnaire, the scores of the IDDM (insulin dependent diabetes mellitus) and NIDDM (non-insulin-dependent diabetes mellitus) groups differed in terms of the type of diabetes treatment \[[@B21-ijerph-16-04441]\]. In addition, in a study by Black on older Mexican Americans with diabetes, the current type of diabetes treatment was associated with depressive symptoms \[[@B22-ijerph-16-04441]\]. The study by Hermanns showed the difference in the proportion of individuals with type 1 and 2 diabetes without insulin treatment and those with type 2 diabetes with insulin treatment who were diagnosed with clinical and subclinical depression \[[@B23-ijerph-16-04441]\].

Therefore, the present study aimed to examine the association between the different types of diabetes treatment and depressive symptoms. In particular, the depressive symptoms of patients with diabetes who were on pharmacologic treatments (oral agents, insulin injection, and both oral agent medications and insulin injection) were assessed in terms of sex.

2. Materials and Methods {#sec2-ijerph-16-04441}
========================

2.1. Data Collection and Participants {#sec2dot1-ijerph-16-04441}
-------------------------------------

This study used data from The Korea Community Health Survey (CHS) in 2011--2016. The CHS is a cross-sectional, annual, nationwide public health survey, which has been performed by the Korea Center for Disease Control and Prevention (KCDC) since 2008. The surveyed population is registered adult residents aged 19 years and older in the community health center. The sample design is a complex, stratified, multistage, probability-cluster sampling design. The survey is conducted by a trained interviewer in a one-on-one interview in Korean through computer-assisted personal interview (CAPI) \[[@B24-ijerph-16-04441]\]. The CHS data are openly published. Additionally, participants' information was fully anonymized and unidentified prior to analysis. Accordingly, ethical approval was not required for this study. Ethical approval of the CHS was obtained from the KCDC (2010-02CON-22-P; 2011-05CON-04-C; 2012-07CON-01-2C; 2013-06EXP-01-3C; 2014-08EXP-09-4C-A; 2016-10-01-P-A). The dataset is available on The CHS website (<https://chs.cdc.go.kr/chs/index.do>).

The total number of respondents in this survey was 1,372,650. However, only respondents aged 30 years or older (*n* = 1,220,729) were selected. Two-stage filtering was performed to identify patients with diabetes who were undergoing treatment. First, patients who answered yes to the question "Have you ever been diagnosed with diabetes by a doctor?" were included (*n* = 128,474). Second, only those who answered yes to the question "Are you currently being treated?" were included among them (*n* = 115,990). There were no missing data in the questionnaire that asked for the types of diabetes treatment. Individuals with missing data on covariate variables were further excluded. Therefore, a final sample population of 99,752 was included in the analysis. Of these, 50,774 were male and 48,978 were female.

2.2. Dependent Variable {#sec2dot2-ijerph-16-04441}
-----------------------

Self-reported depressive symptom was considered as a dependent variable. The following question was included in the questionnaire: "Have you ever felt sad or desperate enough to cause disruption to your daily life over two consecutive weeks in the last year?" The respondents were classified who answered yes as having depressive symptoms and those who answered no as having no depressive symptoms. Those who responded with "Don't know" and "No response" were excluded.

2.3. Independent Variable {#sec2dot3-ijerph-16-04441}
-------------------------

The type of diabetes treatment used to control blood glucose was considered an independent variable. This study used the CHS question "What is the treatment you are doing to manage your blood glucose? Please answer all" to set the interest variable. The possible responses to the questions include the following: insulin injections (yes, no), oral agent medications (oral agents; yes, no), non-pharmacologic therapy (exercise, diet; yes, no). Among the patients, those who answered that they were only treated with non-pharmacological therapy were excluded to examine the association between the different type of pharmacological diabetes treatments and depression.

2.4. Control Variables {#sec2dot4-ijerph-16-04441}
----------------------

The covariates were as follows: age, socioeconomic (SES) factors, health-related factors, and the year of the survey. For SES factors, educational level, marital status, occupation (white collar, pink collar, blue collar, and others), monthly household income, and region of residence were considered. The monthly household income was categorized into six groups. At the start of the investigation, 1000 KRW was equivalent to 0.93 USD \[[@B25-ijerph-16-04441]\]. Health-related factors included alcohol status (whether they drink more than one cup of alcohol during their lifetime), smoking status (whether they smoke more than five packs during their lifetime), walking activities, perceived health status, perceived stress, body mass index, and a history or diagnosis of hypertension and dyslipidemia. Walking activities were assessed by using the following questionnaire: "How many days did you walk at least 10 minutes at a time in the last week?" The responses were classified as follows: None or 1 day per week as inactive, 2--3 days a week as low, 4--5 days a week as middle, and 6--7 days a week as high.

2.5. Statistical Analysis {#sec2dot5-ijerph-16-04441}
-------------------------

χ^2^ test and logistics regression analysis were used for the analysis. All the analyses were performed by classifying the patients according to sex (male and female). χ^2^ test was used to examine the significant difference in depressive symptoms depending on the different types of pharmacological treatments for diabetes and to control covariates, such as age, SES factors, health-related factors, and year. A *p* value \<0.05 was considered statistically significant. Logistic regression analysis was conducted to determine adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analysis was performed according to the different types of treatments for diabetes and depressive symptoms. Statistical analyses were performed by using the Statistical Analysis System software version 9.4 (SAS Institute Inc., Cary, NC, USA).

3. Results {#sec3-ijerph-16-04441}
==========

3.1. Study Population {#sec3dot1-ijerph-16-04441}
---------------------

[Table 1](#ijerph-16-04441-t001){ref-type="table"} shows the general characteristics of the study population. Of the total diabetes patients who were undergoing diabetes treatment, 90,182 (90.4%) were treated with oral agents and 7049 (7.1%) were treated with oral agents and insulin injection. Insulin injection was the least used (2521; 2.5%). Among the male and female diabetes patients, 2911 (2.9%) and 5207 people (5.2%) had depressive symptoms, respectively, indicating a higher proportion of women affected. As for the depressive symptoms according to the type of treatment, in men, treatment with both oral agents and insulin injection were the most frequently used at 5.7%, followed by insulin injection at 5.1%. Oral agents were the least frequently used at 2.6%. In women, treatment with both oral agents and insulin injection were the most frequently used at 8.2%, followed by insulin injection at 6.2%. Oral agents were the least frequently used at 5.0%.

3.2. Association between Type of Diabetes Treatment and Depressive Symptoms {#sec3dot2-ijerph-16-04441}
---------------------------------------------------------------------------

[Table 2](#ijerph-16-04441-t002){ref-type="table"} shows the results of the factors associated with the depressive symptoms of the diabetes patients. The logistic regression analyses adjusted for covariates revealed that the type of diabetes treatment was related to the depressive symptoms of the diabetes patients. In addition, the type of diabetes treatment was more closely related to the symptoms of depression in men with diabetes than in women with diabetes. Compared with taking oral agents, in both men and women, insulin injections more likely caused depressive symptoms. However, the results of women were not significant as compared with those of men (OR = 1.27; 95% CI: 1.04--1.56 vs OR = 1.17, 95% CI: 0.98--1.41). The male and female diabetes patients who received oral agents and insulin injections were the most likely to have depressive symptoms than the diabetes patients with one type of treatment. This showed statistically significant results for both men and women (OR = 1.41, 95% CI: 1.25--1.60 and OR = 1.35, 95% CI: 1.22--1.50, respectively).

3.3. Results of Subgroup Analyses {#sec3dot3-ijerph-16-04441}
---------------------------------

[Table 3](#ijerph-16-04441-t003){ref-type="table"} shows the results of the subgroup analyses of the association of age, educational level, walking activity, and body mass index with depressive symptoms. In most cases, in both men and women, insulin injection showed higher OR values than the reference value for oral agents, but many results of the subgroup analyses were not significant. In both men and women, oral agents and insulin injection together had higher OR values than the reference value for oral agents, with most of the patients showing significant results. The male patients treated with oral agents and insulin injection showed that the age of 40 to 49 had the highest OR values (OR = 1.89, 95% CI: 1.28--2.81) and the age of 60--69 had the lowest OR values (OR = 1.28, 95% CI: 1.02--1.62). In body mass index, the OR value of underweight was not significant and that of normal weight was the lowest (OR = 1.36, 95% CI: 1.11--1.67). The female treated with oral agents and insulin injection showed a similar trend to the male except for body mass index. The age of 40--49 had the highest OR value (OR = 1.54, 95% CI: 1.04--2.28), and the results for the age of 60--69 were not significant. In body mass index, the OR value of underweight was not significant. Normal weight had the highest OR value (OR = 1.46, 95% CI: 1.22--1.74), overweight had a lower OR value (OR = 1.35, 95% CI: 1.08--1.67), and obesity had the lowest OR value (OR = 1.27, 95% CI: 1.07--1.50). This was a tendency different from the results of men.

4. Discussion {#sec4-ijerph-16-04441}
=============

This study investigated the association between the types of treatment and depressive symptoms among diabetes patients undergoing diabetes treatment by dividing sex, using nationally represented data. The depressive symptoms in both male and female patients treated with diabetes varied according to the type of diabetes treatment. In all diabetes patients undergoing diabetes treatment, women reported more depressive symptoms than men. However, in examining the factors of depressive symptoms, it was found that men were more affected by depressive symptoms than women, depending on the type of diabetes treatment. As with the previous investigation, the overall likelihood of experiencing depressive symptoms in all the diabetes patients was higher for women than for men \[[@B12-ijerph-16-04441],[@B26-ijerph-16-04441]\]. However, according to type of treatment, men had a greater risk of experiencing depressive symptoms than women \[[@B27-ijerph-16-04441]\].

In the male diabetes patients, in line with previous studies \[[@B15-ijerph-16-04441],[@B22-ijerph-16-04441],[@B23-ijerph-16-04441]\], showed that treatment with "oral agent and insulin injection" or "insulin injection" was more likely to cause depressive symptoms than treatment with "oral agent" alone. Consistently with a previous study, the patients who were using insulin showed more depressive symptoms. In the Sample description section of the study by Hermanns, of 376 diabetes patients, 53 had clinical depression. Of these patients, 16 were receiving type 1 diabetes treatment (30.2%); 11 were receiving type 2 diabetes treatment without insulin treatment (20.8%); and 26 were receiving type 2 diabetes treatment with insulin (49.0%). Of the 71 patients with subclinical depression, 31%, 22.5% and 46.5% were receiving the aforementioned treatments, respectively \[[@B23-ijerph-16-04441]\].

In female diabetes patients, oral agents and insulin injection significantly caused more depressive symptoms than oral agents alone according to statistics. Statistically significant results for insulin injection were difficult to obtain. However, the characteristics of the study population in our study showed that treatment with insulin injection resulted in a higher proportion of patients with depressive symptoms than treatment with oral agents. Previous studies showed that treatment with insulin injection affects depressive symptoms in diabetes patients. In a study that used PAID questionnaires to investigate the treatment methods for type 2 diabetes patients and their relationship to emotional distresses, the mean PAID score was 14.7 in the "diet alone" group and 17.8 in the "oral medication" group. "Insulin" had the highest score of 24.6 \[[@B15-ijerph-16-04441]\]. In Black's study of older Mexican American diabetes patients, "insulin" had the highest OR value (OR = 1.83; 95% CI: 1.30--2.59), followed by "both insulin and OHA (oral hypoglycemic agent)" (OR = 1.79; 95% CI: 1.10--2.89). "OHAs" had the lowest OR value (OR = 0.72; 95% CI: 0.51--0.99) \[[@B22-ijerph-16-04441]\].

Our results for the male patients showed that the OR was highest for the oral agents and insulin injection group. That is, patients who took both oral agent medication and insulin injection tended to show depressive symptoms more often than patients who were treated only with insulin. In Welch's study that used PAID, the mean PAID score was lowest for "diet treated" at 10.5 ± 12.8 and highest for "IDDM" at 32.9 ± 20.2. For the "NIDDM" groups, including "insulin treated" (26.4 ± 20.8) and "tablet treated" (24.9 ± 22.1), the score was 25.0 ± 20.9 \[[@B21-ijerph-16-04441]\]. Hermanns reported that PAID questionnaires are useful to examine the depression and emotional problems of diabetes patients \[[@B23-ijerph-16-04441]\]. Therefore, depressive symptoms in patients taking oral medications should not be overlooked. In conclusion, in this study, the diabetes patients who were undergoing diabetes treatment only showed differences in the degree of depressive symptoms depending on their sex and type of diabetes treatment, and all were vulnerable to the risk of depressive symptoms.

This study performed subgroup analyses of depressive symptoms and type of diabetes treatments according to age and body mass index. The results showed that the diabetes patient had a stronger association with depressive symptoms if they used both oral agents and insulin injection. Both male and female patients who received oral agents and insulin injection treatment were most likely to experience depressive symptoms at the age of 40--49 years. This is consistent with previous studies that showed that depression was more prevalent among diabetes patients aged 40--49 years \[[@B28-ijerph-16-04441]\]. Body mass index showed a different trend in the male and female patients. The normal-weight men had the lowest prevalence of depressive symptoms, while the women had the highest prevalence of depressive symptoms. Women were at higher and lower risks of experiencing depression when they were normal-weight and obese, respectively. This is considered to have been affected by the mental stress of the female to achieve normal weight due to the climate of Korean society, in which women care more about their weight than men.

Diabetes patients with depression have a lower quality of life and are less active in disease management than diabetes patients without depression \[[@B8-ijerph-16-04441],[@B29-ijerph-16-04441]\]. Low quality of life and poor management of diseases worsens the depressive symptoms of diabetes patients with depression and eventually leads to a vicious circle that continues to degrade their health and quality of life. Therefore, managing depression in diabetics is very important. Our research is meaningful because we have again emphasized depression in diabetes patients by observing the association between the type of diabetes treatment and depressive symptoms among patients with diabetes. In addition, the bidirectional relationship between diabetes and depressive symptoms is well known \[[@B11-ijerph-16-04441]\]. However, regardless of whether depression adversely affects diabetes or diabetes adversely affects depression, all diabetes patients need treatments to manage their blood glucose. Therefore, our study is significant in that it demonstrates the association between the type of diabetes treatment and depressive symptoms. Furthermore, the strength of our study is that the depressive symptoms of diabetes patients were studied according to sex. Our research has the strength of its results being generalizable to the Korean adult population, as it used nationally representative data.

However, this study has some limitations, as it is conducted only with the aforementioned data. First, due to the bidirectional relationship between diabetes and depression \[[@B11-ijerph-16-04441]\], depression may occur before diabetes onset or treatment. On the contrary, diabetes can lead to or exacerbate depression, which can be caused by the burden of the disease (time, cost, effort) as well as by pathophysiological mechanisms \[[@B15-ijerph-16-04441],[@B30-ijerph-16-04441]\]. Furthermore, if a patient with diabetes neglects to manage diabetes due to depression, the symptoms of diabetes may worsen. However, because the data is cross-sectional in design, the causal relationship between diabetes treatment and depressive symptoms remains unknown. In addition, due to the limitation of the survey items, it was not possible to know when diabetes and depression onset or when they were diagnosed and to know time, cost and efforts to manage diabetes. Therefore, it was not possible to detect patients who already had depression and to estimate the burden of disease in diabetes patients. Second, the presented data such as the depressive symptoms and health status variables were self-reported. Therefore, recall bias was possible. In addition, we used one question that asked about depressive symptoms rather than an objective depression inventory. Moreover, that question was about perceived depressive symptoms. Because there were no questions asked about the depression diagnosis or depression inventory, the responses to the feelings of sadness or depression for \>2 weeks in a year were considered depressive symptoms. Third, the questions about diabetes were inadequate. None of the questions were about the type, duration, severity of diabetes, and glycemic control. Information about diabetes is important because it is closely related to the depressive symptoms and the strategy of treatment may vary accordingly. According to the Treatment Guideline for Diabetes in Korea, insulin injections are prescribed for type 1 diabetes, while oral hypoglycemic agents are prescribed first for type 2 diabetes, and if glycemic control is not good, use of both oral hypoglycemic agents and insulin injections is considered \[[@B31-ijerph-16-04441]\]. Therefore, type 2 diabetic patients who use both oral hypoglycemic agents and insulin injections may have more severe symptoms of diabetes. However, it was impossible to pinpoint the type and severity of diabetes in the data used in the study. In addition, diabetes duration is significantly associated with depression \[[@B32-ijerph-16-04441]\]. However, it could not be adjusted because it was also unknown. Moreover, our measures of the type of treatment for diabetes were based on single questions in the survey, which was too wide to know the details. Thus, the more detailed forms of insulin treatment (injection, pump \[[@B33-ijerph-16-04441]\]) or the ingredients and type of oral agents (metformin, thiazolidinediones, dipeptidyl peptidase-4, etc. \[[@B34-ijerph-16-04441]\]) could not be known. Also, how many times the patient took the oral agent or insulin injection could not be known. Finally, treatment efficacy according to disease management and medication adherence may be associated with depressive symptoms \[[@B35-ijerph-16-04441]\]. However, our study used cross-sectional data, and the questionnaire did not include the efficacy of the medicine, the severity of the disease, and the progress of the disease. Therefore, it is not possible to determine whether treatment efficacy influences the results. These limitations require further study.

The bidirectional association of depressive symptoms with diabetes treatment effects and adherence is also well recognized \[[@B11-ijerph-16-04441],[@B20-ijerph-16-04441]\]. To prevent diabetes complications, blood glucose control should be performed well, and to maintain blood glucose at a proper level, the risk of depression should be avoided. Accordingly, physicians must also manage diabetes patients' mental health, including depressive symptoms. In addition, they should consider the depressive symptoms that diabetes patients may experience according to the type of diabetes treatment before the treatments are taken into account.

5. Conclusions {#sec5-ijerph-16-04441}
==============

This study shows the difference in depressive symptoms according to the type of treatment among diabetes patients between the sexes. Depressive symptoms were more strongly associated with diabetes treatment in male patients than in female patients. Insulin injection was associated with depressive symptoms in diabetes patients. Oral agents and insulin injection had a significant correlation with depressive symptoms in diabetes patients. Oral agents and insulin injection were more likely to cause depressive symptoms than one form of treatment alone. Therefore, physicians should consider diabetes patients' risk for developing depressive symptoms according to sex and the type of diabetes treatment. They should also include a process that provides mental support and treatment when managing all diabetes patients.
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###### 

General characteristics of the study population with depressive symptoms.

  Variables                                        Total    Male    *p*-Value \*   Female   *p*-Value \*                                                   
  ------------------------------------------------ -------- ------- -------------- -------- -------------- ------ ---------- ------ ------ -------- ------ ----------
  **Total**                                        99,752   100.0   2911           2.9      47,863         48.0              5207   5.2    43,771   43.9   
  **Diabetes treatment**                                                                                          \<0.0001                                 \<0.0001
  Oral agents                                      90,182   90.4    2384           2.6      43,415         48.1              4471   5.0    39,912   44.3   
  Insulin injection                                2521     2.5     128            5.1      1273           50.5              157    6.2    963      38.2   
  Oral agents and insulin injection                7049     7.1     399            5.7      3175           45.0              579    8.2    2896     41.1   
  **Age**                                                                                                         \<0.0001                                 0.0006
  30--39                                           1396     1.4     79             5.7      780            55.9              67     4.8    470      33.7   
  40--49                                           7528     7.5     286            3.8      4402           58.5              343    4.6    2497     33.2   
  50--59                                           21,613   21.7    738            3.4      11,794         54.6              1011   4.7    8070     37.3   
  60--69                                           32,185   32.3    850            2.6      15,683         48.7              1592   4.9    14,060   43.7   
  70--79                                           29,785   29.9    793            2.7      12,594         42.3              1774   6.0    14,624   49.1   
  80\~                                             7245     7.3     165            2.3      2610           36.0              420    5.8    4050     55.9   
  **Educational level**                                                                                           \<0.0001                                 0.2868
  Elementary school or less                        44,717   44.8    879            2.0      12,627         28.2              3337   7.5    27,874   62.3   
  Middle school                                    18,166   18.2    607            3.3      9650           53.1              822    4.5    7087     39.0   
  High school                                      24,168   24.2    925            3.8      15,642         64.7              831    3.4    6770     28.0   
  College or over                                  12,701   12.7    500            3.9      9944           78.3              217    1.7    2040     16.1   
  **Marital status**                                                                                              \<0.0001                                 \<0.0001
  Married-cohabit                                  72,774   73.0    2022           2.8      41,690         57.3              2768   3.8    26,294   36.1   
  Married non-cohabitant or bereaved or divorced   25,153   25.2    716            2.8      4972           19.8              2371   9.4    17,094   68.0   
  Unmarried                                        1825     1.8     173            9.5      1201           65.8              68     3.7    383      21.0   
  **Occupation**                                                                                                  \<0.0001                                 \<0.0001
  White collar                                     7244     7.3     246            3.4      5855           80.8              90     1.2    1053     14.5   
  Pink collar                                      8424     8.4     164            1.9      3838           45.6              392    4.7    4030     47.8   
  Blue collar                                      32,561   32.6    752            2.3      20,694         63.6              826    2.5    10,289   31.6   
  Others                                           51,523   51.7    1749           3.4      17,476         33.9              3899   7.6    28,399   55.1   
  **Monthly household income, 1000 KRW**                                                                          \<0.0001                                 \<0.0001
  \~999                                            35,161   35.2    1370           3.9      12,982         36.9              2683   7.6    18,126   51.6   
  1000--1999                                       22,848   22.9    603            2.6      11,569         50.6              1092   4.8    9584     41.9   
  2000--2999                                       15,729   15.8    377            2.4      8401           53.4              627    4.0    6324     40.2   
  3000--3999                                       10,287   10.3    242            2.4      5714           55.5              321    3.1    4010     39.0   
  4000--4999                                       6181     6.2     120            1.9      3535           57.2              212    3.4    2314     37.4   
  5000\~                                           9546     9.6     199            2.1      5662           59.3              272    2.8    3413     35.8   
  **Residency region**                                                                                            \<0.0001                                 \<0.0001
  Urban area--large city                           23,897   24.0    833            3.5      11,457         47.9              1458   6.1    10,149   42.5   
  Urban area--small city                           18,580   18.6    592            3.2      8790           47.3              1041   5.6    8157     43.9   
  Rural area                                       57,275   57.4    1486           2.6      27,616         48.2              2708   4.7    25,465   44.5   
  **Alcohol status**                                                                                              0.5162                                   \<0.0001
  Ever                                             73,066   73.2    2640           3.6      43,232         59.2              3074   4.2    24,120   33.0   
  Never                                            26,686   26.8    271            1.0      4631           17.4              2133   8.0    19,651   73.6   
  **Smoking status**                                                                                              0.0476                                   \<0.0001
  Ever                                             44,517   44.6    2413           5.4      38,972         87.5              623    1.4    2509     5.6    
  Never                                            55,235   55.4    498            0.9      8891           16.1              4584   8.3    41,262   74.7   
  **Walking activity**                                                                                            \<0.0001                                 \<0.0001
  Inactive                                         29,997   30.1    1062           3.5      14,062         46.9              1851   6.2    13,022   43.4   
  Low                                              15,902   15.9    438            2.8      7364           46.3              873    5.5    7227     45.4   
  Middle                                           13,996   14.0    372            2.7      6453           46.1              711    5.1    6460     46.2   
  High                                             39,857   40.0    1039           2.6      19,984         50.1              1772   4.4    17,062   42.8   
  **Perceived health status**                                                                                     \<0.0001                                 \<0.0001
  Good                                             13,026   13.1    160            1.2      8543           65.6              190    1.5    4133     31.7   
  Normal                                           34,556   34.6    628            1.8      19,126         55.3              890    2.6    13,912   40.3   
  Bad                                              52,170   52.3    2123           4.1      20,194         38.7              4127   7.9    25,726   49.3   
  **Perceived stress level**                                                                                      \<0.0001                                 \<0.0001
  Very                                             25,887   26.0    1863           7.2      10,076         38.9              3443   13.3   10,505   40.6   
  Less                                             45,860   46.0    832            1.8      22,838         49.8              1412   3.1    20,778   45.3   
  Low                                              28,005   28.1    216            0.8      14,949         53.4              352    1.3    12,488   44.6   
  **Body mass index (kg/m^2^)**                                                                                   \<0.0001                                 \<0.0001
  Underweight (\~18.4)                             2959     3.0     163            5.5      996            33.7              295    10.0   1505     50.9   
  Normal weight (18.5--22.9)                       33,982   34.1    1040           3.1      15,412         45.4              1794   5.3    15,736   46.3   
  Overweight (23.0--24.9)                          27,470   27.5    754            2.7      14,260         51.9              1198   4.4    11,258   41.0   
  Obesity (25.0\~)                                 35,341   35.4    954            2.7      17,195         48.7              1920   5.4    15,272   43.2   
  **Hypertension diagnosis**                                                                                      0.0027                                   0.0732
  Yes                                              60,434   60.6    1752           2.9      27,451         45.4              3379   5.6    27,852   46.1   
  No                                               39,318   39.4    1159           2.9      20,412         51.9              1828   4.6    15,919   40.5   
  **Dyslipidemia diagnosis**                                                                                      \<0.0001                                 \<0.0001
  Yes                                              32,578   32.7    1078           3.3      13,732         42.2              2308   7.1    15,460   47.5   
  No                                               67,174   67.3    1833           2.7      34,131         50.8              2899   4.3    28,311   42.1   
  **Year**                                                                                                        \<0.0001                                 \<0.0001
  2011                                             14,080   14.1    362            2.6      6660           47.3              627    4.5    6431     45.7   
  2012                                             14,856   14.9    351            2.4      7209           48.5              663    4.5    6633     44.6   
  2013                                             16,061   16.1    462            2.9      7753           48.3              812    5.1    7034     43.8   
  2014                                             17,230   17.3    591            3.4      8204           47.6              1042   6.0    7393     42.9   
  2015                                             18,280   18.3    582            3.2      8746           47.8              993    5.4    7959     43.5   
  2016                                             19,245   19.3    563            2.9      9291           48.3              1070   5.6    8321     43.2   

\* *p*-value is the result of the chi square test. Oral agents, Oral hypoglycemics; KRW, Korean Won;
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###### 

Factors associated with depressive symptoms in diabetes patients.

  Variables                                         Male   Female                
  ------------------------------------------------- ------ -------------- ------ --------------
  **Diabetes treatment**                                                         
   Oral agents                                      1.00   \-             1.00   \-
   Insulin injection                                1.27   (1.04--1.56)   1.17   (0.98--1.41)
   Oral agents and insulin injection                1.41   (1.25--1.60)   1.35   (1.22--1.50)
  **Age**                                                                        
   30--39                                           1.00   \-             1.00   \-
   40--49                                           0.71   (0.54--0.95)   1.20   (0.88--1.62)
   50--59                                           0.73   (0.56--0.97)   1.17   (0.87--1.56)
   60--69                                           0.63   (0.48--0.84)   0.92   (0.68--1.24)
   70--79                                           0.58   (0.44--0.78)   0.82   (0.61--1.11)
   80\~                                             0.44   (0.32--0.62)   0.70   (0.51--0.96)
  **Educational level**                                                          
   Elementary school or less                        1.00   \-             1.00   \-
   Middle school                                    1.01   (0.90--1.14)   1.05   (0.96--1.15)
   High school                                      0.96   (0.86--1.08)   1.12   (1.01--1.24)
   College or over                                  0.90   (0.79--1.04)   1.10   (0.92--1.31)
  **Marital status**                                                             
   Married-cohabit                                  1.00   \-             1.00   \-
   Married non-cohabitant or bereaved or divorced   1.93   (1.74--2.13)   1.40   (1.31--1.50)
   Unmarried                                        1.41   (1.15--1.72)   1.26   (0.94--1.68)
  **Occupation**                                                                 
   White collar                                     1.00   \-             1.00   \-
   Pink collar                                      0.92   (0.74--1.13)   1.14   (0.88--1.48)
   Blue collar                                      0.86   (0.72--1.02)   1.12   (0.87--1.45)
   Others                                           1.81   (1.52--2.16)   1.78   (1.39--2.27)
  **Monthly household income, 1000 KRW**                                         
   \~999                                            1.00   \-             1.00   \-
   1000--1999                                       0.69   (0.62--0.77)   0.82   (0.76--0.89)
   2000--2999                                       0.63   (0.55--0.72)   0.73   (0.66--0.81)
   3000--3999                                       0.58   (0.49--0.68)   0.58   (0.50--0.66)
   4000--4999                                       0.48   (0.38--0.59)   0.71   (0.60--0.83)
   5000\~                                           0.49   (0.40--0.58)   0.61   (0.53--0.71)
  **Residency region**                                                           
   Urban area--large city                           1.00   \-             1.00   \-
   Urban area--small city                           0.84   (0.75--0.95)   0.84   (0.77--0.92)
   Rural area                                       0.74   (0.67--0.81)   0.74   (0.69--0.80)
  **Alcohol status**                                                             
   Ever                                             1.00   \-             1.00   \-
   Never                                            0.90   (0.78--1.03)   0.89   (0.83--0.95)
  **Smoking status**                                                             
   Ever                                             1.00   \-             1.00   \-
   Never                                            1.10   (0.99--1.23)   0.67   (0.60--0.74)
  **Walking activity**                                                           
   Inactive                                         1.00   \-             1.00   \-
   Low                                              0.94   (0.83--1.07)   0.94   (0.86--1.03)
   Middle                                           0.95   (0.83--1.09)   0.95   (0.86--1.05)
   High                                             0.86   (0.78--0.95)   0.90   (0.83--0.97)
  **Perceived health status**                                                    
   Good                                             1.00   \-             1.00   \-
   Normal                                           1.44   (1.21--1.72)   1.14   (0.97--1.35)
   Bad                                              2.53   (2.13--3.00)   1.90   (1.63--2.23)
  **Perceived stress level**                                                     
   Very                                             1.00   \-             1.00   \-
   Less                                             0.24   (0.22--0.26)   0.24   (0.22--0.25)
   Low                                              0.09   (0.08--0.11)   0.10   (0.09--0.11)
  **Body mass index (kg/m^2^)**                                                  
   Underweight (\~18.4)                             1.51   (1.24--1.84)   1.45   (1.25--1.68)
   Normal weight (18.5--22.9)                       1.00   \-             1.00   \-
   Overweight (23.0--24.9)                          0.92   (0.83--1.02)   0.96   (0.88--1.04)
   Obesity (25.0\~)                                 0.92   (0.83--1.02)   0.98   (0.91--1.06)
  **Hypertension diagnosis**                                                     
   Yes                                              1.00   \-             1.00   \-
   No                                               1.04   (0.96--1.14)   1.06   (0.99--1.13)
  **Dyslipidemia diagnosis**                                                     
   Yes                                              1.00   \-             1.00   \-
   No                                               0.75   (0.69--0.82)   0.78   (0.73--0.84)
  **Year**                                                                       
   2011                                             1.00   \-             1.00   \-
   2012                                             0.89   (0.76--1.04)   1.06   (0.94--1.19)
   2013                                             1.15   (0.99--1.34)   1.31   (1.16--1.47)
   2014                                             1.36   (1.18--1.57)   1.58   (1.42--1.77)
   2015                                             1.31   (1.13--1.51)   1.42   (1.27--1.59)
   2016                                             1.17   (1.01--1.36)   1.52   (1.36--1.70)

Oral agents, Oral hypoglycemics; KRW, Korean Won.
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###### 

Subgroup analysis of depressive symptoms with the type of diabetes treatment by covariates \*.

  Variables                       Diabetes Treatment                                
  ------------------------------- -------------------- ------ -------------- ------ --------------
  **Male**                                                                          
  **Age**                                                                           
   30--39                         \+                   \+                    \+     
   40--49                         1.00                 0.98   (0.51--1.89)   1.89   (1.28--2.81)
   50--59                         1.00                 1.17   (0.78--1.74)   1.53   (1.19--1.96)
   60--69                         1.00                 1.47   (1.02--2.10)   1.28   (1.02--1.62)
   70--79                         1.00                 1.26   (0.84--1.91)   1.34   (1.05--1.70)
   80\~                           \-                                                
  **Educational level**                                                             
   Elementary school or less      \+                   \+                    \+     
   Middle school                  1.00                 1.38   (0.90--2.12)   1.36   (1.03--1.78)
   High school                    1.00                 1.53   (1.10--2.12)   1.53   (1.23--1.91)
   College or over                1.00                 0.95   (0.55--1.65)   1.75   (1.30--2.35)
  **Walking activity**                                                              
   Inactive                       1.00                 1.31   (0.94--1.84)   1.55   (1.27--1.88)
   Low                            1.00                 1.32   (0.76--2.32)   1.46   (1.03--2.06)
   Middle                         1.00                 1.07   (0.60--1.89)   1.49   (1.04--2.13)
   High                           1.00                 1.27   (0.91--1.78)   1.22   (0.98--1.52)
  **Body mass index (kg/m^2^)**                                                     
   Underweight (\~18.4)           1.00                 2.13   (1.00--4.54)   1.66   (0.98--2.79)
   Normal weight (18.5--22.9)     1.00                 1.33   (0.98--1.81)   1.36   (1.11--1.67)
   Overweight (23.0--24.9)        1.00                 1.33   (0.88--2.02)   1.46   (1.13--1.89)
   Obesity (25.0\~)               1.00                 0.96   (0.62--1.50)   1.41   (1.13--1.76)
  **Female**                                                                        
  **Age**                                                                           
   30--39                         \+                   \+                    \+     
   40--49                         1.00                 1.22   (0.67--2.22)   1.54   (1.04--2.28)
   50--59                         1.00                 1.03   (0.67--1.57)   1.42   (1.12--1.80)
   60--69                         1.00                 1.30   (0.93--1.83)   1.18   (0.98--1.42)
   70--79                         1.00                 1.21   (0.86--1.71)   1.38   (1.15--1.64)
   80\~                           \-                                                
  **Educational level**                                                             
   Elementary school or less      \+                   \+                    \+     
   Middle school                  1.00                 1.26   (0.80--1.98)   1.31   (1.01--1.70)
   High school                    1.00                 1.09   (0.73--1.63)   1.45   (1.12--1.88)
   College or over                1.00                 0.76   (0.36--1.60)   1.84   (1.15--2.95)
  **Walking activity**                                                              
   Inactive                       1.00                 1.32   (0.98--1.78)   1.45   (1.23--1.72)
   Low                            1.00                 1.08   (0.66--1.76)   1.39   (1.08--1.79)
   Middle                         1.00                 1.80   (1.11--2.89)   1.23   (0.91--1.66)
   High                           1.00                 0.88   (0.62--1.24)   1.24   (1.04--1.49)
  **Body mass index (kg/m^2^)**                                                     
   Underweight (\~18.4)           1.00                 1.14   (0.56--2.35)   1.27   (0.79--2.03)
   Normal weight (18.5--22.9)     1.00                 1.03   (0.76--1.40)   1.46   (1.22--1.74)
   Overweight (23.0--24.9)        1.00                 1.28   (0.87--1.88)   1.35   (1.08--1.67)
   Obesity (25.0\~)               1.00                 1.30   (0.94--1.79)   1.27   (1.07--1.50)

+: The number is insufficient and cannot be calculated; \* Age, sex, educational level, marital status, occupation, monthly household income, residency region, alcohol status, smoking status, perceived health status, walking activity, stress level, body mass index, hypertension diagnosis, dyslipidemia diagnosis, and year variables were adjusted. Oral agents, Oral hypoglycemics;
